Advertisement
Research Article

Development of a Humanized Antibody with High Therapeutic Potential against Dengue Virus Type 2

  • Pi-Chun Li,

    Affiliations: Graduate Institute of Life Sciences, National Defense Medical Center, Taipei, Taiwan, Institute of Cellular and Organismic Biology, Academia Sinica, Taipei, Taiwan

    X
  • Mei-Ying Liao,

    Affiliation: Institute of Cellular and Organismic Biology, Academia Sinica, Taipei, Taiwan

    X
  • Ping-Chang Cheng,

    Affiliation: Institute of Cellular and Organismic Biology, Academia Sinica, Taipei, Taiwan

    X
  • Jian-Jong Liang,

    Affiliation: Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan

    X
  • I-Ju Liu,

    Affiliation: Institute of Cellular and Organismic Biology, Academia Sinica, Taipei, Taiwan

    X
  • Chien-Yu Chiu,

    Affiliation: Institute of Cellular and Organismic Biology, Academia Sinica, Taipei, Taiwan

    X
  • Yi-Ling Lin,

    Affiliation: Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan

    X
  • Gwong-Jen J. Chang,

    Affiliation: Arbovirus Diseases Branch, Division of Vector-Borne Infectious Diseases, Centers for Disease Control and Prevention, Public Health Service, United States Department of Health and Human Services, Fort Collins, Colorado, United States of America

    X
  • Han-Chung Wu mail

    hcw0928@gate.sinica.edu.tw

    Affiliations: Graduate Institute of Life Sciences, National Defense Medical Center, Taipei, Taiwan, Institute of Cellular and Organismic Biology, Academia Sinica, Taipei, Taiwan

    X
  • Published: May 01, 2012
  • DOI: 10.1371/journal.pntd.0001636

Media Coverage of this Article

Found additional news media or blog coverage for the article? Please let us know.